Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
Background: CA 15.3 is elevated in most patients with distant metastatic breast cancer who had prognostic information. The present study was performed to estimate predictive ability of CA 15.3 in assessment of symptomatic metastasis in patients with breast cancer. Materials and Methods: During five...
Main Authors: | Amir Bahrami-Ahmadi, Fariborz Makarian, Mohammad R Mortazavizadeh, Mohammad F Yazdi, Mehdi Chamani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=9;spage=850;epage=854;aulast=Bahrami-Ahmadi |
Similar Items
-
CA15.3 Serum Concentrations in Older Women with Infiltrating Ductal Carcinomas of the Breast
by: Álvaro Ruibal, et al.
Published: (2014-10-01) -
Treatment efficacy of 153Sm-EDTMP for painful bone metastasis
by: Narjess Ayati, et al.
Published: (2013-04-01) -
Clinical significance of detecting CEA, CA199, AFP, HCG, CA153, CA125 in postoperative treatment of patients with ovarian cancer
by: Xue Pan, et al.
Published: (2016-10-01) -
Clinical significance of serum tumor markers CA153, CA125, CA72-4 and FIB, IL-6 levels detection in ovarian cancer
by: Zhong-Jie Liu, et al.
Published: (2018-01-01) -
Treatment efficacy of 153Sm-EDTMP for painful bone metastasis
by: Narjess Ayati, et al.
Published: (2013-04-01)